As of 2025-12-28, the Relative Valuation of Inhibrx Inc (INBX) is 518.74 USD. This relative valuation is based on P/E multiples. With the latest stock price at 80.21 USD, the upside of Inhibrx Inc based on Relative Valuation is 546.7%.
The range of the Relative Valuation is (70.11) - 1,440.76 USD.
| Range | Selected | |
| Trailing P/E multiples | 9.1x - 15.8x | 12.4x |
| Forward P/E multiples | 9.2x - 16.0x | 12.6x |
| Fair Price | (70.11) - 1,440.76 | 518.74 |
| Upside | -187.4% - 1696.2% | 546.7% |
| Date | P/E |
| 2025-12-26 | -10.43 |
| 2025-12-24 | -10.45 |
| 2025-12-23 | -10.16 |
| 2025-12-22 | -11.38 |
| 2025-12-19 | -11.20 |
| 2025-12-18 | -11.10 |
| 2025-12-17 | -10.81 |
| 2025-12-16 | -10.61 |
| 2025-12-15 | -9.91 |
| 2025-12-12 | -10.35 |
| 2025-12-11 | -10.69 |
| 2025-12-10 | -10.99 |
| 2025-12-09 | -11.56 |
| 2025-12-08 | -12.16 |
| 2025-12-05 | -11.64 |
| 2025-12-04 | -11.37 |
| 2025-12-03 | -10.79 |
| 2025-12-02 | -10.70 |
| 2025-12-01 | -10.51 |
| 2025-11-28 | -10.94 |
| 2025-11-26 | -10.88 |
| 2025-11-25 | -10.76 |
| 2025-11-24 | -10.54 |
| 2025-11-21 | -10.92 |
| 2025-11-20 | -10.39 |
| 2025-11-19 | -10.68 |
| 2025-11-18 | -10.09 |
| 2025-11-17 | -10.06 |
| 2025-11-14 | -10.29 |
| 2025-11-13 | -9.71 |
| 2025-11-12 | -9.54 |
| 2025-11-11 | -10.13 |
| 2025-11-10 | -10.28 |
| 2025-11-07 | -10.50 |
| 2025-11-06 | -10.54 |
| 2025-11-05 | -10.70 |
| 2025-11-04 | -10.67 |
| 2025-11-03 | -10.59 |
| 2025-10-31 | -10.62 |
| 2025-10-30 | -10.21 |
| 2025-10-29 | -10.02 |
| 2025-10-28 | -8.91 |
| 2025-10-27 | -7.66 |
| 2025-10-24 | -7.45 |
| 2025-10-23 | -3.69 |
| 2025-10-22 | -4.10 |
| 2025-10-21 | -4.88 |
| 2025-10-20 | -4.97 |
| 2025-10-17 | -4.85 |
| 2025-10-16 | -4.76 |